|
|
Volumn , Issue , 2013, Pages
|
|
Novel therapeutics in hepatocellular carcinoma: how can we make progress?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ANIMAL;
CARCINOMA, HEPATOCELLULAR;
DRUG DESIGN;
DRUG EFFECTS;
HUMAN;
LIVER NEOPLASMS;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
MORTALITY;
PATHOLOGY;
RISK FACTOR;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOMARKERS, TUMOR;
CARCINOMA, HEPATOCELLULAR;
DRUG DESIGN;
HUMANS;
LIVER NEOPLASMS;
MOLECULAR TARGETED THERAPY;
RISK FACTORS;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
|
EID: 84964963397
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e137 Document Type: Review |
|
Times cited : (16)
|
|
References (0)
|